Amit Patel was appointed to the Board in March 2017 and serves on the Audit and Risk Management and Nomination Committees.
Amit Patel is a Co-Founder and CEO of Vios Medical, which has created an FDA-cleard patient management platform that integrates IoT-based monitoring, remote care services, and big data analytics to alleviate gaps in patient vigilance across in-hospital and home enviroments. Through a value-based innovation model, Vios is initially commercialising a step-down monitorin solution across major hospital systems in India, and is now part of the TMCx program at Texas Medical Center to catalyse market entry in the US.
Prior to founding Vios, Amit was with HeartFlow where he created a joint go-to-market strategy with GE Healthcare’s imaging division, managed the DeFACTO clinical study across multiple UK sites, and developed a health economic story for the NHS. Prior to HeartFlow, Amit was with Medtronic’s Corporate Development group and was responsible for aquisitions, minority investements, and joint ventures spanning existing businesses and strategic whitespace areas. Amit has a MBA from Stanford University and a Bachelors of Biomedical Engineering from the University of Minnesota.
|COMPANY NAME||APPOINTED||RETIRED / RESIGNED|
|ImpediMed Limited||March 17||–|